Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 4
Treatment-assignment count: 1
Stratification count: 0
Drug Development Ahead Of Cdx Context
BRAF V600E
solid tumor basket · Small Molecule Inhibitor
BRAF V600E is flagged as drug development ahead of cdx context because public trials show inclusion required evidence in 6 contexts. FDA CDx context should be reviewed manually.
Threshold snippets
Fragmentation view
Threshold count: 7
Common snippets: BRAF V600E | BRAF V600E | KRAS G12C
Threshold label: Moderate
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Not Found
CDx maturity score: 1/5
Confidence: Medium
Patent-density signal
Diagnostic appendix
Signal count: 0
Recent signals: 0
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT02327169 | https://clinicaltrials.gov/study/NCT05710406 | https://clinicaltrials.gov/study/NCT05370469 | https://clinicaltrials.gov/study/NCT05578092 | https://clinicaltrials.gov/study/NCT06322095 | https://clinicaltrials.gov/study/NCT03994796